Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Satyapon & PartnersKritsana Mingtongkhum and Shantanu Ajit Tambe of Satyapon & Partners provide a guide to claiming trademark infringement damages in Thailand, and suggest an approach that could offer quicker resolution and yield a higher amount -
Sponsored by Remfry & SagarCyril Abrol of Remfry & Sagar reports that India is not confining itself to small steps as the country aims to take a giant leap in the global space race
-
Sponsored by FirstLaw PCHyoun-Ja Park and Minji Ryan Kim of FirstLaw PC analyse two significant developments as South Korea attempts to strengthen its protection of trade secrets and proprietary information involving industrial and national core technologies
-
Sponsored by Anand and AnandTusha Malhotra and Tanvi Bhatnagar of Anand and Anand say technological advances such as those in AI are presenting new challenges in protecting the personality rights of celebrities in India and necessitate a delicate balancing act
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains what types of bio inventions are deemed eligible for patent protection in Japan and draws comparisons with US practice
-
Sponsored by Shiga International Patent OfficeThe Japan Patent Office has published additional case examples designed to clarify the patentability of AI-related technology. Fumio Takahashi of Shiga International Patent Office explains the new guidance
